Researchers from the Okayama University in Japan report photoimmunotherapy to be effective against elusive gastric cancer cells following transduction with the gene that expresses the extracellular domain protein of HER2. The results are published in the February 2016 edition of the journal Small Molecule Therapeutics in February 2016.
“Gastric cancer is one of the most common malignancies worldwide, making it the third leading cause of cancer-related death,” explain…Continue
Added by Editorial Team on March 15, 2016 at 1:00pm — No Comments
A new study supported by funding from the National Institutes of Health and the Yale Cancer Center sheds light on how melanoma cells change from benign to malignant, and how the complex interaction between the cells and their surrounding environment affects outcomes of the cancer.
The transition from the radial growth patterns of benign melanoma cells to the vertical patterns of malignant cells has long been a mystery to researchers. But a study from the lab of Andre Levchenko, the…Continue
Added by Editorial Team on March 14, 2016 at 11:00am — No Comments
Several drugs now being used to treat heart failure and atrial arrhythmia also show promise as DNA disruptors in cancer cells and could be readily repurposed as anticancer agents, according to a new study by Yale researchers which was supported by the National Institute of General Medical Sciences, CureSearch for Children’s Cancer, and the Yale Center for Molecular Discovery.
Cardiac glycosides, which are bioactive natural products found in certain plants and insects, aid in cardiac…Continue
Added by Editorial Team on March 11, 2016 at 12:30pm — No Comments
Contributing Editors: Amit Kumar, Ph.D and Robert Berman
For nearly 45 years, the national dialogue, when it comes to cancers, has remained essentially the same. We have been racing for the cure, praying for the cure, searching for the cure, researching for the cure, raising money for the cure, funding the cure, and developing treatments for the cure. Curing cancer has become the “national cancer objective”.…Continue
Added by Editorial Team on March 11, 2016 at 9:30am — No Comments
Senior leaders from more than a dozen biopharmaceutical companies came together today with world-class academic clinicians from four leading cancer centers, representatives from oncology non-profits, the FDA, and other key stakeholder organizations to advance the most promising avenues for curing cancer: accelerating the development of investigational drug combination therapies of two or more investigational treatments which may hold great promise for cancer patients.
Added by Editorial Team on March 7, 2016 at 2:00pm — No Comments